Value through Innovation18 April 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

19.04.2012

Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)

- For media outside of the U.S.A. only
19.04.2012

First ever data investigating interferon-free treatment in hepatitis C patients who have liver cirrhosis shows high viral cure rate

- For media outside of the U.S.A. only
18.04.2012

Leading medical and patient organisations join forces to improve stroke prevention in atrial fibrillation

- For NON-US and NON-UK Media Only
18.04.2012

Dabigatran etexilate (Pradaxa®) associated with significantly lower rates of fatal and traumatic intracranial haemorrhage compared with Warfarin

- For Non-US, UK & Canadia Media Only
16.03.2012

Pradaxa® (dabigatran etexilate) – first new oral anticoagulant in nearly 60 years receives final NICE recommendation for stroke prevention in atrial fibrillation in the UK1

- For NON-US, NON-UK & NON- Canadian Healthcare Media Only
12.03.2012

Boehringer Ingelheim sets up its first Asian Veterinary Research & Development Center in Shanghai

02.03.2012

Porcine circovirus research projects from France and Spain awarded

29.02.2012

Boehringer Ingelheim expands capabilities in biopharmaceutical process science

21.02.2012

Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies

03.02.2012

Boehringer Ingelheim, GWT and the TU Dresden sign diabetes research collaboration

31.01.2012

FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes

- For Non-U.S. and Non-UK Media
26.01.2012

Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply

26.01.2012

Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*

- FOR NON-US MEDIA ONLY
14.12.2011

Boehringer Ingelheim significantly expands its supply center for China

09.12.2011

Boehringer Ingelheim completes patient entry for Phase III trial
programme in Hepatitis C

- For media outside the U.S.
08.12.2011

Linagliptin demonstrates meaningful improvement in glycaemic control in initial combination therapy with metformin

- EX US, UK and UAE Medical Media Only. Under embargo until 08 Dec, 10 am CET
07.12.2011

Winners of the Making More Health Competition Bring Fresh Innovation to Solving Problems in Health

01.12.2011

Boehringer Ingelheim and AVEO Pharmaceuticals announce manufacturing agreement for ficlatuzumab